{"id":194396,"url":"https://lda.senate.gov/api/v1/clients/194396/?format=json","client_id":140,"name":"CELGENE CORPORATION","general_description":"Biopharmaceutical company","client_government_entity":false,"client_self_select":null,"state":"NJ","state_display":"New Jersey","country":"US","country_display":"United States of America","ppb_state":"NJ","ppb_state_display":"New Jersey","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2016-06-09","registrant":{"id":400703105,"url":"https://lda.senate.gov/api/v1/registrants/400703105/?format=json","house_registrant_id":null,"name":"EMPIRE CONSULTING GROUP","description":"Government Relations","address_1":"1717 K Street NW","address_2":"9th Floor","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20006","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"MIKE MCKAY","contact_telephone":"+1 202-787-5740","dt_updated":"2026-01-29T14:42:13.419000-05:00"}}